Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Protective effects of BPC 157 in rats with experimentally induced lower extremity ischemia-reperfusion injury
Scientific reports, 2026
LCP2 mediates SUV39H1-driven cellular senescence-related chemoresistance in natural killer/T-cell lymphoma
Cell death & disease, 2026
Spinal Implant-Associated Infection in Type 2 and Type 1 Diabetes: Phenotype-Specific Inflammatory Features and Therapeutic Response to Semaglutide
JOR spine, 2026;9(2):e70196
Inter-organ communication shapes human metabolic tissue states and resolves anti-diabetic drug response modes in a six-tissue microphysiological system
bioRxiv : the preprint server for biology, 2026
Middle-aged mice treated with GHK-Cu peptide administered intraperitoneally or intranasally show behavioral rescue but divergent hippocampal aging programs
Research square, 2026
Evaluation of the Efficacy of Semaglutide Dose Escalation in Reducing HbA1c Levels and Insulin Dose in Type 2 Diabetes Patients: Real-World Semaglutide Data from Türkiye, SEMA-TR Study
Journal of clinical medicine, 2026;15(11)
Benefits of Incretin Therapy on Ovarian Function: A Scientific Literature Review
International journal of molecular sciences, 2026;27(11)
Impact of GLP-1 Receptor Agonists on Chronic Low Back Pain in Patients with Obesity: A Prospective Pilot Cohort Study
medRxiv : the preprint server for health sciences, 2026
Type B insulin resistance with glycemic extremes: a case report and literature review
Frontiers in endocrinology, 2026;17:1852784
GLP-1 Receptor Agonists and Dual GIP/GLP-1 Receptor Agonists in Children and Adolescents with Obesity: Clinical Outcomes and the Impact of Nutritional and Behavioral Co-Interventions-A Systematic Review
Nutrients, 2026;18(11)
Retrospective Comparative Study of Oral Versus Subcutaneous Semaglutide in Patients with Type 2 Diabetes Mellitus
International journal of molecular sciences, 2026;27(11)
Glucagon-like peptide-1 receptor agonist, semaglutide, attenuates intravenous self-administration of fentanyl in female rats
bioRxiv : the preprint server for biology, 2026
BPC-157 as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers
Pharmaceutics, 2026;18(5)
A rationally designed 18-amino acid peptide with potential as GLP-1 receptor agonist
Frontiers in pharmacology, 2026;17:1789257
Injectable Peptides in Sports Medicine: A Structured Narrative Review of Evidence, Safety, and Antidoping Implications
JBJS reviews, 2026;14(5)
Clinical impact of tirzepatide on patients with chronic obstructive pulmonary disease
Frontiers in pharmacology, 2026;17:1838392
Psychosocial Outcomes in Telemedicine and Long-Acting Incretin-Specific Behavioral Intervention
Obesity science & practice, 2026;12(3):e70149
Efficacy and safety of novel formulation of semaglutide injection: A multicentre, randomized, comparative, active controlled, phase 3 study in comparison with reference biologic in Indian patients with type 2 diabetes mellitus
Metabolism open, 2026;30:100476
Comparative effectiveness of tirzepatide versus GLP-1 receptor agonists on the risk of venous thromboembolism in patients with obesity: a real-world cohort study
Frontiers in medicine, 2026;13:1820366
Structure-Property-Performance Engineering of Hydrogel Depots for Long-Acting Peptide Delivery
bioRxiv : the preprint server for biology, 2026